Auris Health company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

Total Raised




About Auris Health

Auris Health is integrating robotics, micro-instrumentation, endoscope design, sensing, and data science into one platform to enhance physician capabilities.

Auris Health Headquarter Location

150 Shoreline Drive

Redwood City, California, 94065,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Auris Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Auris Health in 1 CB Insights research brief, most recently on Sep 10, 2020.

Expert Collections containing Auris Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Auris Health is included in 4 Expert Collections, including Digital Health.


Digital Health

12,917 items

Startups recreating how healthcare is delivered



1,795 items

This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.


Medical Devices

11,001 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,900 items

Auris Health Patents

Auris Health has filed 372 patents.

The 3 most popular patent topics include:

  • Medical equipment
  • Endoscopy
  • Surgical instruments
patents chart

Application Date

Grant Date


Related Topics




Endoscopy, Surgical instruments, Medical equipment, Digestive system procedures, Surgical procedures and techniques


Application Date


Grant Date



Related Topics

Endoscopy, Surgical instruments, Medical equipment, Digestive system procedures, Surgical procedures and techniques



Latest Auris Health News

Is Evidence of Generic Industry Skepticism Enough to Preclude a Finding of a Motivation to Combine?

May 4, 2022

To embed, copy and paste the code into your website or blog: <iframe frameborder="1" height="620" scrolling="auto" src="//" style="border: 2px solid #ccc; overflow-x:hidden !important; overflow:hidden;" width="100%"></iframe> AURIS HEALTH, INC., v. INTUITIVE SURGICAL OPERATIONS, INC., Before Dyk, Prost, and Reyna. Summary: Evidence of generic industry skepticism cannot, by itself, form the basis to preclude a finding of motivation to combine. Auris Health requested Inter Partes Review of a patent directed to a robotic surgery system with a servo-pulley mechanism that allows surgeons to remotely manipulate and quickly swap out surgical instruments using a controller, thereby reducing surgery time. Auris argued that the challenged claims were obvious over the combination of two patent publications called Smith and Faraz. Auris argued that a skilled artisan would have been motivated to combine Smith and Faraz to decrease the number of assistants needed for the surgery and robotize some tasks. The patent owner responded that a skilled artisan would not have been motivated to combine Smith and Faraz as the “surgeons were skeptical about performing robotic surgery in the first place.” The Board agreed that the combination of Smith and Faraz disclosed every limitation of the challenged claims. However, the Board concluded that a skilled artisan would not have been motivated to combine those references because of the general skepticism about using robotic systems during surgery at the time of the invention. Auris appealed. The Federal Circuit vacated and remanded the Board’s decision. The Federal Circuit held that, while specific evidence of skepticism in the industry related to a specific combination of references may be used in a motivation-to-combine analysis, evidence of generic industry skepticism alone cannot preclude a finding of motivation to combine. The Federal Circuit held that the Board “impermissibly” relied on the patent owner’s expert testimony on general skepticism for performing telesurgery in finding a lack of motivation to combine. The Federal Circuit therefore remanded for the Board to determine whether the evidence was sufficient to establish a motivation to combine. Judge Reyna dissented, arguing that the majority’s finding announces a new inflexible and rigid legal principle that it is “impermissible” to consider evidence of artisan’s skepticism towards a field in determining motivation to combine.

  • When was Auris Health founded?

    Auris Health was founded in 2007.

  • Where is Auris Health's headquarters?

    Auris Health's headquarters is located at 150 Shoreline Drive, Redwood City.

  • What is Auris Health's latest funding round?

    Auris Health's latest funding round is Acquired.

  • How much did Auris Health raise?

    Auris Health raised a total of $733.29M.

  • Who are the investors of Auris Health?

    Investors of Auris Health include Johnson & Johnson, Mithril Capital Management, Lux Capital, Wellington Management, PFM Health Sciences and 7 more.

  • Who are Auris Health's competitors?

    Competitors of Auris Health include ACTIV Surgical, Bionaut Labs, Vicarious Surgical, Quantum Surgical, CMR Surgical and 13 more.

You May Also Like


Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support. The company was formerly known as Cardiorobotics and Innvoention Technologies.

CMR Surgical Logo
CMR Surgical

CMR Surgical is a surgical robotics company developing universal robotic systems for minimal access surgery. The company's vision is to make minimal access (or keyhole) surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically.

ACTIV Surgical

Activ is a developer of software to augment surgeons. It develops an AI/ML platform called ActivEdge, which is designed to provide real-time intelligence and visualization to surgeons. The company was founded in 2017 and is based in Boston, Massachusetts.

Quantum Surgical Logo
Quantum Surgical

Quantum Surgical is a surgical robotics start-up building next-generation smart tools for minimally invasive therapies, beginning with interventional oncology. The robotic platform will enable physicians to better assess, plan, and treat a broad spectrum of medical conditions. The Company is developing end-to-end solutions for interventional oncology.

Intuitive Surgical

Intuitive Surgical develops, manufactures and markets robotic surgical systems under the da Vinci Surgical brand.

Theator Logo

Theator offers an online platform where surgeons can record surgeries and use them as educational material for improving future procedures. It was founded in 2018 and is based in Palo Alto, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.